Volume 29, Number 11—November 2023
Synopsis
Outbreak of Pandoraea commovens Infections among Non–Cystic Fibrosis Intensive Care Patients, Germany, 2019–2021
Table 1
Patient characteristics in an outbreak of Pandoraea commovens among non–cystic fibrosis intensive care patients, Germany, 2019–2021*
Characteristics |
Value† |
IQR |
---|---|---|
Sex | ||
M | 12 (50) | NA |
F |
12 (50) |
NA |
Age, y |
67 (45–81) |
61–69 |
Length of stay, d |
51 (0–131) |
32–105 |
Discharged alive |
17 (74) |
NA |
Time to detect P. commovens, d |
22 (0–131) |
11–45 |
Intensive care unit admission | 22 (96) | NA |
Invasive ventilation | 15 (65) | NA |
Renal replacement therapy |
7 (30) |
NA |
Surgery |
15 (65) |
NA |
Antimicrobial drug therapy | ||
During hospitalization | 23 (100) | NA |
During previous 3 mo |
14 (82) |
NA |
Immunosuppressed |
5 (22) |
NA |
Charlson Comorbidity Index |
6 (0–13) |
3–6 |
Vascular disease or disorder | ||
Myocardial infarction | 4 (17) | NA |
Congestive heart failure | 14 (61) | NA |
Peripheral vascular disease | 3 (13) | NA |
Cerebrovascular accident |
3 (13) |
NA |
Chronic lung disease |
6 (26) |
NA |
Peptic ulcer disease |
1 (4) |
NA |
Moderate to severe liver disease |
3 (13) |
NA |
Moderate to severe CKD |
9 (39) |
NA |
Diabetes mellitus | 5 (22) | NA |
Diabetes mellitus with end-organ damage |
4 (17) |
NA |
Cancer | ||
Solid tumor | 2 (9) | NA |
Leukemia | 2 (9) | NA |
Lymphoma | 2 (9) | NA |
*Data reflect 23 cases, except for sex, median age, and median length of hospitalization (n = 24). CKD, chronic kidney disease. †Values are no. (%) or median (range).
Page created: October 03, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.